Thursday, May 13, 2010

More headway:

Yesterday one of my doctors showed me the latest newsletter from Johns Hopkins. It was devoted to CFIDS and the newest research breakthroughs.

Today a feature in the Guardian U.K. effectively illustrates the more pernicious aspects of the illness. (Note: in the U.K., CFIDS/CFS is frequently referred to as M.E., for Myalgic Encepholopathy.)

As most of you know, it's what I've had for the past 19 years and thus far, despite enormous progress as to its etiology (the Centers for Disease Control announced in April 2006 that five genetic markers had been isolated in those of us with CFIDS; it appears almost certain the trigger is the XMRV retrovirus or another, similar virus) there is still no effective treatment.

Fingers remain unendingly crossed.

The Guardian U.K. piece:

No comments: